Onyx Pharmaceuticals (ONXX +4.4%) is trading higher today after Goldman Sachs ups the shares to...

|By:, SA News Editor

Onyx Pharmaceuticals (ONXX +4.4%) is trading higher today after Goldman Sachs ups the shares to buy on valuation. Goldman says the company has a strong balance sheet, and ongoing trials expected within the next 12-18 months could increase the sales potential for Nexavar, a cancer-drug it sells with partner Bayer (BAYRY.PK +1%).